BRIACELL THERAPEUTICS CORP. (BCTXZ) Operating income 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTXZ) annual operating income history from SEC filings — each fiscal year as reported.
-$36.1MFY2026 · since FY2021: -$7.0M → -$36.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$36.1M | -32.5% |
| FY2025 | -$27.2M | +18.4% |
| FY2024 | -$33.3M | -43.2% |
| FY2023 | -$23.3M | -52.2% |
| FY2022 | -$15.3M | -119.2% |
| FY2021 | -$7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXZ financial trends
BCTXZ RevenueBCTXZ Net incomeBCTXZ Net marginBCTXZ Gross profitBCTXZ Gross marginBCTXZ Operating marginBCTXZ Operating cash flowBCTXZ Free cash flowBCTXZ Capital expendituresBCTXZ Return on equityBCTXZ Stock buybacksBCTXZ Dividends paidBCTXZ Total assetsBCTXZ Total liabilitiesBCTXZ Shareholders’ equityBCTXZ overview →